Overview

Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This is a study to evaluate safety, tolerability and PK of DKF-310 IM injection in healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Dongkook Pharmaceutical Co., Ltd.
Treatments:
Donepezil